Inhibitory Antibodies
-
F1741 Anti-GDF8/Myostatin Antibody (Domagrozumab)Summary: Anti-GDF8/Myostatin Antibody (Domagrozumab) -
F1742 Anti-NGF/bNGF Antibody (Fasinumab)Summary: Anti-NGF/bNGF Antibody (Fasinumab) -
F1743 Anti-NGF/bNGF Antibody (Fulranumab)Summary: Anti-NGF/bNGF Antibody (Fulranumab) -
F1744 Anti-SLC1A5/ASCT2 Antibody (Idactamab)Summary: Anti-SLC1A5/ASCT2 Antibody (Idactamab) -
F1745 Anti-LYPD3/C4.4A Antibody (Lupartumab)Summary: Anti-LYPD3/C4.4A Antibody (Lupartumab) -
F1746 Anti-TFPI Antibody (Marstacimab)Summary: Anti-TFPI Antibody (Marstacimab) -
F1747 Anti-TPBG Antibody (NaptumomAb)Summary: Anti-TPBG Antibody (NaptumomAb) -
F1748 Anti-TSPAN26/CD37 Antibody (Naratuximab)Summary: Anti-TSPAN26/CD37 Antibody (Naratuximab) -
F1749 Anti-MADCAM1 Antibody (Ontamalimab)Summary: Anti-MADCAM1 Antibody (Ontamalimab) -
F1750 Anti-LINGO1 Antibody (Opicinumab)Summary: Anti-LINGO1 Antibody (Opicinumab)

